Oncology is a highly evidence-based speciality and cancer data are critical to treatment planning. However, as precision medicine capabilities grow, those decisions likely will become more complex. PERSIST aim to show the potential of big data technology for making fundamental changes in care delivery for cancer survivors.
Core technological and organizational challenges
PERSIST can help especially to the health services like patient-reported outcomes, patient satisfaction scoring, identifying high-risk patients and giving them the appropriate treatment, and supporting patients who are either at high risk of reoccurrence.
Market change motivation
PERSIST can help especially to the health services like patient-reported outcomes, patient satisfaction scoring, identifying high-risk patients and giving them the appropriate treatment, and supporting patients who are either at high risk of reoccurrence.
To alleviate the rising cost pressure, payers are demanding more robust evidence of therapies, leading to the stratification. It is no longer the case that one treatment is necessarily suitable for all patients. Advances in science and technology platforms are likely to progress faster in oncology than in other disease areas, due to terminal disease prevalence and the corresponding increase in patients’ risk appetite. In a changing world, where innovation enables patients to access information and insights more readily than ever before, they will fast become the most relevant stakeholder in the healthcare ecosystem, thus conferring the need for a change in emphasis from other players in the system.